BlackRock’s Enliven Therapeutics ELVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $59.5M | Sell |
|
|||||
|
2025
Q1 | $59M | Buy |
|
|||||
|
2024
Q4 | $66.7M | Buy |
|
|||||
|
2024
Q3 | $75M | Buy |
|
|||||
|
2024
Q2 | $63.8M | Buy |
|
|||||
|
2024
Q1 | $31.9M | Sell |
|
|||||
|
2023
Q4 | $25.6M | Buy |
|
|||||
|
2023
Q3 | $21.4M | Buy |
|
|||||
|
2023
Q2 | $31.6M | Buy |
|
|||||
|
2023
Q1 | $740K | Buy |
|
|||||
|
2022
Q4 | $469K | Buy |
|
|||||
|
2022
Q3 | $252K | Sell |
|
|||||
|
2022
Q2 | $150K | Buy |
|
|||||
|
2022
Q1 | $202K | Buy |
|
|||||
|
2021
Q4 | $234K | Buy |
|
|||||
|
2021
Q3 | $420K | Buy |
|
|||||
|
2021
Q2 | $613K | Sell |
|
|||||
|
2021
Q1 | $3.85M | Buy |
|
|||||
|
2020
Q4 | $9.79M | Buy |
|
|||||
|
2020
Q3 | $6.89M | Sell |
|
|||||
|
2020
Q2 | $9.48M | Buy |
|